Molecular Mechanisms of Luteolin Against Atopic Dermatitis Based on Network Pharmacology and in vivo Experimental Validation

References

• Li H, Zhang Z, Zhang H, Guo Y, Yao Z. Update on the pathogenesis and therapy of atopic dermatitis. Clin Rev Allergy Immunol. 2021;61(3):324–338. doi:10.1007/s12016-021-08880-3
   PubMed Web of Science ®Google Scholar
• Saini S, Pansare M. New insights and treatments in atopic dermatitis. Immunol Allergy Clin North Am. 2021;41(4):653–665. doi:10.1016/j.iac.2021.07.005
   Web of Science ®Google Scholar
• Reed B, Blaiss MS. The burden of atopic dermatitis. Allergy Asthma Proc. 2018;39(6):406–410. doi:10.2500/aap.2018.39.4175
   PubMed Web of Science ®Google Scholar
• Moniaga CS, Tominaga M, Takamori K. The pathology of type 2 inflammation-associated itch in atopic dermatitis. Diagnostics. 2021;11(11):2090. doi:10.3390/diagnostics11112090
   Web of Science ®Google Scholar
• Souwer Y, Szegedi K, Kapsenberg ML, De Jong EC. IL-17 and IL-22 in atopic allergic disease. Curr Opin Immunol. 2010;22(6):821–826. doi:10.1111/j.1600-065X.2011.01027.x
   Web of Science ®Google Scholar
• Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011;242(1):233–246. doi:10.1111/j.1600-065X.2011.01027.x
   PubMed Web of Science ®Google Scholar
• Zheng T, Fan M, Wei Y, et al. Huangbai liniment ameliorates skin inflammation in atopic dermatitis. Front Pharmacol. 2021;12:726035. doi:10.3389/fphar.2021.726035
   PubMed Web of Science ®Google Scholar
• Wu S, Pang Y, He Y, et al. A comprehensive review of natural products against atopic dermatitis: flavonoids, alkaloids, terpenes, glycosides and other compounds. Biomed Pharmacother. 2021;140:111741. doi:10.1016/j.biopha.2021.111741
   PubMed Web of Science ®Google Scholar
• Lin Y, Shi R, Wang X, Shen HM. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets. 2008;8(7):634–646. doi:10.2174/156800908786241050
   PubMed Web of Science ®Google Scholar
• Pandurangan AK, Esa NM. Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: a review. Asian Pac J Cancer Prev. 2014;15(14):5501–5508. doi:10.7314/APJCP.2014.15.14.5501
   PubMedGoogle Scholar
• Gendrisch F, Esser PR, Schempp CM, Wölfle U. Luteolin as a modulator of skin aging and inflammation. Biofactors. 2021;47(2):170–180. doi:10.1002/biof.1699
   PubMed Web of Science ®Google Scholar
• Baolin L, Weiwei W, Ning T. Topical application of luteolin inhibits scratching behavior associated with allergic cutaneous reaction in mice. Planta Med. 2005;71(5):424–428. doi:10.1055/s-2005-864137
   PubMed Web of Science ®Google Scholar
• Kibble M, Saarinen N, Tang J, Wennerberg K, Mäkelä S, Aittokallio T. Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products. Nat Prod Rep. 2015;32(8):1249–1266. doi:10.1039/c5np00005j
   PubMed Web of Science ®Google Scholar
• Noor F, Tahir Ul Qamar M, Ashfaq UA, Albutti A, Alwashmi ASS, Aljasir MA. Network pharmacology approach for medicinal plants: review and assessment. Pharmaceuticals. 2022;15(5):572. doi:10.3390/ph15050572
   Web of Science ®Google Scholar
• Mandlik DS, Mandlik SK, Patel SS. Sarsasapogenin and fluticasone combination improves DNFB induced atopic dermatitis lesions in BALB/c mice. Immunopharmacol Immunotoxicol. 2021;43(6):767–777. doi:10.1080/08923973.2021.1981375
   PubMed Web of Science ®Google Scholar
• Leung DY, Hirsch RL, Schneider L, et al. Thymopentin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol. 1990;85(5):927–933.
   PubMed Web of Science ®Google Scholar
• Han NR, Moon PD, Yoo MS, Ryu KJ, Kim HM, Jeong HJ. Regulatory effects of chrysophanol, a bioactive compound of AST2017-01 in a mouse model of 2,4-dinitrofluorobenzene-induced atopic dermatitis. Int Immunopharmacol. 2018;62:220–226. doi:10.1016/j.intimp.2018.06.046
   Web of Science ®Google Scholar
• Hsin KY, Ghosh S, Kitano H. Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology. PLoS One. 2013;8(12):e83922. doi:10.1371/journal.pone.0083922
   PubMed Web of Science ®Google Scholar
• Lu L, Guan QX, Tian YX, Lin JX, Liang SW, Wang SM. Simulation and prediction of material foundation of Rhei Radix et Rhizoma for ischemic stroke based on molecular docking technology. Zhong Yao Cai. 2015;38(4):781–785.
   PubMedGoogle Scholar
• Xu SN, Zhuang L, Zhai YY, et al. Material basis and mechanism of erzhi pill for preventing osteoporosis based on network pharmacology. Chinese Pharm J. 2018;24:1913–1920.
   Google Scholar
• Motoyama K, Tanida Y, Sakai A, Higashi T, Kaneko S, Arima H. Anti-allergic effects of novel sulfated polysaccharide sacran on mouse model of 2,4-Dinitro-1-fluorobenzene-induced atopic dermatitis. Int J Biol Macromol. 2018;108:112–118. doi:10.1016/j.ijbiomac.2017.11.155
   Web of Science ®Google Scholar
• Tang L, Li XL, Wan LP, et al. Ameliorative effect of orally administered different linoleic acid/α-linolenic acid ratios in a mouse model of DNFB-induced atopic dermatitis. J Funct Foods. 2020;65:103754. doi:10.1016/j.jff.2019.103754
   Web of Science ®Google Scholar
• Glatz M, Jo JH, Kennedy EA, et al. Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis. PLoS One. 2018;13(2):e0192443. doi:10.1371/journal.pone.0192443
   PubMed Web of Science ®Google Scholar
• Choi EJ, Debnath T, Tang Y, Ryu YB, Moon SH, Kim EK. Topical application of Moringa oleifera leaf extract ameliorates experimentally induced atopic dermatitis by the regulation of Th1/Th2/Th17 balance. Biomed Pharmacother. 2016;84:870–877. doi:10.1016/j.biopha.2016.09.085
   PubMed Web of Science ®Google Scholar
• Batista DI, Perez L, Orfali RL, et al. Profile of skin barrier proteins (filaggrin, claudins 1 and 4) and Th1/Th2/Th17 cytokines in adults with atopic dermatitis. J Eur Acad Dermatol Venereol. 2015;29(6):1091–1095. doi:10.1111/jdv.12753
   PubMed Web of Science ®Google Scholar
• Kaczynska A, Klosinska M, Janeczek K, Zarobkiewicz M, Emeryk A. Promising immunomodulatory effects of bacterial lysates in allergic diseases. Front Immunol. 2022;13:907149. doi:10.3389/fimmu.2022.907149
   Web of Science ®Google Scholar
• Salvati L, Cosmi L, Annunziato F. From emollients to biologicals: targeting atopic dermatitis. Int J Mol Sci. 2021;22(19):10381. doi:10.3390/ijms221910381
   Web of Science ®Google Scholar
• Zhang Y, Wang J, Zhou S, et al. Flavones hydroxylated at 5, 7, 3’ and 4’ ameliorate skin fibrosis via inhibiting activin receptor-like kinase 5 kinase activity. Cell Death Dis. 2019;10(2):124. doi:10.1038/s41419-019-1333-7
   Web of Science ®Google Scholar
• Mertowska P, Mertowski S, Smarz-Widelska I, Grywalska E. Biological role, mechanism of action and the importance of interleukins in kidney diseases. Int J Mol Sci. 2022;23(2):647. doi:10.3390/ijms23020647
   Web of Science ®Google Scholar
• Peluzzo AM, Autieri MV. Challenging the paradigm: anti-inflammatory interleukins and angiogenesis. Cells. 2022;11(3):587. doi:10.3390/cells11030587
   Web of Science ®Google Scholar
• Ruan X, Du P, Zhao K, et al. Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking. Chin Med. 2020;15:62. doi:10.1186/s13020-020-00346-6
   PubMed Web of Science ®Google Scholar
• Aihaiti Y, Song Cai Y, Tuerhong X, et al. Therapeutic effects of naringin in rheumatoid arthritis: network pharmacology and experimental validation. Front Pharmacol. 2021;12:672054. doi:10.3389/fphar.2021.672054
   PubMed Web of Science ®Google Scholar
• Kristjánsson S, Shimizu T, Strannegård IL, Wennergren G. Eosinophil cationic protein, myeloperoxidase and tryptase in children with asthma and atopic dermatitis. Pediatr Allergy Immunol. 1994;5(4):223–229. doi:10.1111/j.1399-3038.1994.tb00244.x
   Google Scholar
• Wiesolek HL, Bui TM, Lee JJ, et al. Intercellular adhesion molecule 1 functions as an efferocytosis receptor in inflammatory macrophages. Am J Pathol. 2020;190(4):874–885. doi:10.1016/j.ajpath.2019.12.006
   PubMed Web of Science ®Google Scholar
• Grobe W, Bieber T, Novak N. Pathophysiology of atopic dermatitis. J Dtsch Dermatol Ges. 2019;17(4):433–440. doi:10.1111/ddg.13819
   Web of Science ®Google Scholar
• Chu M, Tsang MS, He R, Lam CW, Quan ZB, Wong CK. The active compounds and therapeutic mechanisms of pentaherbs formula for oral and topical treatment of atopic dermatitis based on network pharmacology. Plants. 2020;9(9):1166. doi:10.3390/plants9091166
   Web of Science ®Google Scholar
• Agha-Majzoub R, Becker RP, Schraufnagel DE, Chan LS. Angiogenesis: the major abnormality of the keratin-14 IL-4 transgenic mouse model of atopic dermatitis. Microcirculation. 2005;12(6):455–476. doi:10.1080/10739680591003297
   Web of Science ®Google Scholar
• Jung MK, Hur DY, Song SB, et al. Tannic acid and quercetin display a therapeutic effect in atopic dermatitis via suppression of angiogenesis and TARC expression in Nc/Nga mice. J Invest Dermatol. 2010;130(5):1459–1463. doi:10.1038/jid.2009.401
   Web of Science ®Google Scholar
• Furue M, Chiba T, Tsuji G, et al. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergol Int. 2017;66(3):398–403. doi:10.1016/j.alit.2016.12.002
   PubMed Web of Science ®Google Scholar
• Guttman-Yassky E, Waldman A, Ahluwalia J, Ong PY, Eichenfield LF. Atopic dermatitis: pathogenesis. Semin Cutan Med Surg. 2017;36(3):100–103. doi:10.12788/j.sder.2017.036
   PubMed Web of Science ®Google Scholar
• Tokura Y, Hayano S. Subtypes of atopic dermatitis: from phenotype to endotype. Allergol Int. 2022;71(1):14–24. doi:10.1016/j.alit.2021.07.003
   PubMed Web of Science ®Google Scholar
• Tsai YC, Tsai TF. Overlapping Features of psoriasis and atopic dermatitis: from genetics to immunopathogenesis to phenotypes. Int J Mol Sci. 2022;23(10):5518. doi:10.3390/ijms23105518
   PubMed Web of Science ®Google Scholar
• Hofmann MA, Fluhr JW, Ruwwe-Glösenkamp C, Stevanovic K, Bergmann KC, Zuberbier T. Role of IL-17 in atopy-A systematic review. Clin Transl Allergy. 2021;11(6):e12047. doi:10.1002/clt2.12047
   Web of Science ®Google Scholar
• Xiong X, Huang C, Wang F, et al. Qingxue jiedu formulation ameliorated DNFB-induced atopic dermatitis by inhibiting STAT3/MAPK/NF-κB signaling pathways. J Ethnopharmacol. 2021;270:113773. doi:10.1016/j.jep.2020.113773
   Web of Science ®Google Scholar
• Zeng H, Zhao B, Zhang D, et al. Viola yedoensis Makino formula alleviates DNCB-induced atopic dermatitis by activating JAK2/STAT3 signaling pathway and promoting M2 macrophages polarization. Phytomedicine. 2022;103:154228. doi:10.1016/j.phymed.2022.154228
   Web of Science ®Google Scholar
• Bao L, Zhang H, Chan LS. The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis. JAKSTAT. 2013;2(3):e24137. doi:10.4161/jkst.24137
   PubMedGoogle Scholar
• Nakashima C, Yanagihara S, Otsuka A. Innovation in the treatment of atopic dermatitis: emerging topical and oral Janus kinase inhibitors. Allergol Int. 2022;71(1):40–46. doi:10.1016/j.alit.2021.10.004
   PubMed Web of Science ®Google Scholar